Morgan Stanley’s Enzymotec Ltd ENZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-187,170
Closed -$2.22M 6878
2017
Q4
$2.22M Buy
+187,170
New +$2.22M ﹤0.01% 3944
2017
Q1
Sell
-5,311
Closed -$35K 6684
2016
Q4
$35K Buy
5,311
+300
+6% +$1.98K ﹤0.01% 5847
2016
Q3
$35K Sell
5,011
-7,197
-59% -$50.3K ﹤0.01% 5735
2016
Q2
$102K Sell
12,208
-42,961
-78% -$359K ﹤0.01% 5232
2016
Q1
$498K Buy
55,169
+6,683
+14% +$60.3K ﹤0.01% 4447
2015
Q4
$475K Buy
48,486
+33,288
+219% +$326K ﹤0.01% 4580
2015
Q3
$137K Buy
15,198
+6,459
+74% +$58.2K ﹤0.01% 5273
2015
Q2
$73K Buy
8,739
+5,283
+153% +$44.1K ﹤0.01% 5734
2015
Q1
$25K Sell
3,456
-10,899
-76% -$78.8K ﹤0.01% 5998
2014
Q4
$110K Buy
14,355
+9,199
+178% +$70.5K ﹤0.01% 5509
2014
Q3
$35K Buy
5,156
+3,926
+319% +$26.7K ﹤0.01% 5841
2014
Q2
$17K Sell
1,230
-10,027
-89% -$139K ﹤0.01% 6070
2014
Q1
$248K Sell
11,257
-695
-6% -$15.3K ﹤0.01% 5008
2013
Q4
$323K Buy
+11,952
New +$323K ﹤0.01% 4775